Case Study: Achieving 172% of Enrollment Targets for a Global Phase 3 Trial
Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The trial required a patient population of generally healthy adults aged ≥50, stratified into three age groups. Challenge Vaccine season brings a surge of clinical research activity—especially for flu-related studies. At the time of this trial, several … Read more